🏛️ Verified NIH Record • Updated 2025-02-06

Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE (NCT05357404)

Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE (PREVUE-VALVE)

🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Cardiovascular Research Foundation, New York

🩺 Plain-English Summary (8th-Grade Level)

The PREVUE-VALVE study will establish reliable, population-based estimates of Valvular Heart Disease (VHD) prevalence among older Americans and allow for the development and validation of several innovative tools to aid in the detection and diagnosis of Valvular Heart Disease (VHD).

Who can join: Review the eligibility criteria below.

Location: Hawthorne Effect — Walnut Creek, California

Age range: 65 Years to 85 Years

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

  • Hawthorne Effect — Walnut Creek, California

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Valvular Heart Disease

Explore by condition: All Valvular Heart Disease clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗